Michael Scheurer, PhD, MPH, FACE
Picture
Michael Scheurer, PhD, MPH, FACE
Professor
Positions
- Professor
-
Pediatrics
Hematology-Oncology
Baylor College of Medicine
Houston, Texas United States
- Adjunct Professor
-
University of Texas School of Public Health
- Director, Population Sciences Biorepository
-
Dan L Duncan Comprehensive Cancer Center
Baylor College of Medicine
Houston, Texas United States
- Director
-
Research and Tissue Support Services Core
Texas Children's Hospital
- Director
-
Center for Epidemiology & Population Health
Baylor College of Medicine
- Associate Director for Inclusive Leadership and Culture
-
Dan L Duncan Comprehensive Cancer Center
Baylor College of Medicine
- Sidney L. and Donald F. Faust Chair of Pediatric Cancer Epidemiology
-
Texas Children's Hospital
Addresses
- Pavilion Tower II (Office)
-
Suite 1530.25
Houston, TX 77030
United States
- Feigin Tower (Lab)
-
Suite C1160
Houston, TX 77030
United States
Education
- Post-Doctoral Fellowship at MD Anderson Cancer Center
- 07/2006 - Houston, Texas United States
- Molecular Epidemiology
- MPH from University of Alabama at Birmingham
- 06/1999 - Birmingham, Alabama United States
- Epidemiology
- PhD from University of Texas Health Science Center
- 12/2004 - Houston, Texas United States
- Epidemiology
Professional Statement
Dr. Scheurer is a molecular epidemiologist at Texas Children’s Cancer Center and in the Cancer Prevention and Population Sciences Program of the Dan L Duncan Comprehensive Cancer Center at Baylor College of Medicine. He also serves at the Associate Director for Inclusive Leadership and Culture and the Co-Director of the Integrated Biobanking Shared Resource for the Cancer Center and the Director of the Population Sciences Biorepository, an Advanced Technology Core of the College.Dr. Scheurer’s research focuses on viruses, environmental insults, and immune function as risk factors for cancer development and progression. His laboratory looks for novel ways to identify and catalog molecular markers of these exposures as risk factors for the development of cancer and for risk of adverse outcomes. He is actively involved with two large international research groups focused on two rare tumors: the Brain Tumor Epidemiology Consortium and the Childhood Leukemia International Consortium.
His research also focuses on understanding the factors that are associated with cancer health disparities and working toward interventions to overcome those disparities.
Websites
Selected Publications
- Badr H, Rouce R, Scheurer ME, Lulla P, Mims M, Reddy P "Bringing CAR T cell therapy trials to underserved populations." Cancer Cell. 2023;41(12):2007-2010. Pubmed PMID: 37890490
- Winestone LE, Getz KD, Li Y, Burrows E, Scheurer ME, Tam V, Gramatges MM, Wilkes JJ, Miller TP, Seif AE, Rabin KR, Fisher BT, Aplenc R "Racial and ethnic disparities in acuity of presentation among children with newly diagnosed acute leukemia." Pediatr Blood Cancer. 2024;71(1):e30726. Pubmed PMID: 37856154
- Stricker E, Peckham-Gregory EC, Scheurer ME "HERVs and Cancer-A Comprehensive Review of the Relationship of Human Endogenous Retroviruses and Human Cancers." Biomedicines. 2023;11(3):936. Pubmed PMID: 36979914
- Dharia P, Swartz MD, Bernhardt MB, Chen H, Gramatges MM, Lupo PJ, Brown AL, Scheurer ME "Clinical and demographic factors contributing to asparaginase- associated toxicities in children with acute lymphoblastic leukemia." Leuk Lymphoma. 2022;63(12):2948-2954. Pubmed PMID: 35895075
- Brown AL, Sok P, Raghubar KP, Lupo PJ, Richard MA, Morrison AC, Yang JJ, Stewart CF, Okcu MF, Chintagumpala MM, Gajjar A, Kahalley LS, Conklin H, Scheurer ME "Genetic susceptibility to cognitive decline following craniospinal irradiation for pediatric central nervous system tumors." Neuro Oncol. 2023;25(9):1698-1708. Pubmed PMID: 37038335
- Shakeel O, Lupo PJ, Strong S, Arora M, Scheurer ME "A brief review of the current knowledge on environmental toxicants and risk of pediatric cancers." Pediatr Hematol Oncol. 2022;39(3):193-202. Pubmed PMID: 34665984
- Schraw JM, Petridou ET, Bonaventure A, Dockerty JD, Karalexi M, Ntzani E, Infante-Rivard C, Clavel J, Bracci PM, McKean-Cowdin R, Roman E, Kane E, Erdmann F, Schüz J, Mueller BA, Scheurer ME "Breastfeeding and risk of childhood brain tumors: a report from the Childhood Cancer and Leukemia International Consortium." Cancer Causes Control. 2023;34(11):1005-1015. Pubmed PMID: 37421504
- Hoang TT, Rosales O, Burgess E, Lupo PJ, Scheurer ME, Oluyomi AO "Clustering of Pediatric Brain Tumors in Texas, 2000-2017." Toxics. 2023;11(4):351. Pubmed PMID: 37112578
- Zobeck M, Bernhardt MB, Kamdar KY, Rabin KR, Lupo PJ, Scheurer ME "Novel and replicated clinical and genetic risk factors for toxicity from high-dose methotrexate in pediatric acute lymphoblastic leukemia." Pharmacotherapy. 2023;43(3):205-214. Pubmed PMID: 36764694
- Lupo PJ, Petrick LM, Hoang TT, Janitz AE, Marcotte EL, Schraw JM, Arora M, Scheurer ME "Using primary teeth and archived dried spots for exposomic studies in children: Exploring new paths in the environmental epidemiology of pediatric cancer." Bioessays. 2021;43(9):e2100030. Pubmed PMID: 34106479
- Schraw JM, Bailey HD, Bonaventure A, Mora AM, Roman E, Mueller BA, Clavel J, Petridou ET, Karalexi M, Ntzani E, Ezzat S, Rashed WM, Marcotte EL, Spector LG, Metayer C, Kang AY, Magnani C, Miligi L, Dockerty JD, Mejίa-Aranguré JM, ..., Scheurer ME "Infant feeding practices and childhood acute leukemia: Findings from the Childhood Cancer & Leukemia International Consortium." Int J Cancer. 2022;151(7):1013-1023. Pubmed PMID: 35532209
- Harris RD, Taylor OA, Raghubar KP, Matheus Gonzalez M, Zobeck M, Gramatges MM, Rabin KR, Scheurer ME, Brown AL "Episodes of acute methotrexate-related neurotoxicity linked to compromised long-term neurocognitive function." Pediatr Blood Cancer. 2024;71(9):e31169. Pubmed PMID: 38961583
- Harris RD, Bernhardt MB, Zobeck MC, Taylor OA, Gramatges MM, Schafer ES, Lupo PJ, Rabin KR, Scheurer ME, Brown AL "Ethnic-specific predictors of neurotoxicity among patients with pediatric acute lymphoblastic leukemia after high-dose methotrexate." Cancer. 2023;129(8):1287-1294. Pubmed PMID: 36692972
- Williams LA, Haynes D, Sample JM, Lu Z, Hossaini A, McGuinn LA, Hoang TT, Lupo PJ, Scheurer ME "PM2.5, vegetation density, and childhood cancer: a case- control registry-based study from Texas 1995-2011." J Natl Cancer Inst. 2024;116(6):876-884. Pubmed PMID: 38366656
- Raghubar KP, Chambers T, Hill RM, Taylor O, Hockenberry M, Hooke MC, Mitby P, Moore IK, Brown AL, Scheurer ME "Longitudinal investigation of suicidal ideation and associated factors during pediatric acute lymphoblastic leukemia chemotherapy." Psychooncology. 2022;31(10):1782-1789. Pubmed PMID: 35986586
- Brown AL, Raghubar KP, Taylor OA, Bernhardt MB, Kahalley LS, Pan W, Lupo PJ, Hockenberry MJ, Scheurer ME "Prospective patient-reported symptom profiles associated with pediatric acute lymphoblastic leukemia relapse." Support Care Cancer. 2021;29(5):2455-2464. Pubmed PMID: 32929538
- Castellanos MI, Oluyomi AO, Chambers TM, Gramatges MM, Winestone LE, Lupo PJ, Scheurer ME "Ethnic disparities in childhood leukemia survival by border residence: A Texas population-based analysis." Cancer. 2023;129(8):1276-1286. Pubmed PMID: 36805949
- Brown AL, Sok P, Taylor O, Woodhouse JP, Bernhardt MB, Raghubar KP, Kahalley LS, Lupo PJ, Hockenberry MJ, Scheurer ME "Cerebrospinal Fluid Metabolomic Profiles Associated With Fatigue During Treatment for Pediatric Acute Lymphoblastic Leukemia." J Pain Symptom Manage. 2021;61(3):464-473. Pubmed PMID: 32889041
- Vasquez P, Escalante J, Raghubar KP, Kahalley LS, Taylor OA, Moore IK, Hockenberry MJ, Scheurer ME, Brown AL "Association between fatigue and sleep disturbances during treatment for pediatric acute lymphoblastic leukemia and posttreatment neurocognitive performance." Pediatr Blood Cancer. 2022;69(5):e29507. Pubmed PMID: 34889514
- Scheurer ME, Zhou R, Gilbert MR, Bondy ML, Sulman EP, Yuan Y, Liu Y, Vera E, Wendland MM, Youssef EF, Stieber VW, Komaki RR, Flickinger JC, Kenyon LC, Robins HI, Hunter GK, Crocker IR, Chao ST, Pugh SL, Armstrong TS "Germline polymorphisms in MGMT associated with temozolomide-related myelotoxicity risk in patients with glioblastoma treated on NRG Oncology/RTOG 0825." Neurooncol Adv. 2022;4(1):vdac152. Pubmed PMID: 36299794
Log In to edit your profile
